Home Page
Awareness Building
Amyloidosis Info
Amyloidosis Centers
ATTRwt & ATTRv
Important Clinical Trials
Patient Registry
Upcoming Events
Webinars
About Us
Contact Us
Resources
Treatment Centers
Awareness Items
AMY Blogs
Patient's Day
In Memoriam
Donations
Diflunisal Shortage!
Click Here
Were you diagnosed with Cerebral Amyloid Angiopathy (CAA)?
Click Here
|
Amyloidosis Support Groups
We are a phone call or email away! 24/7 TOLL FREE HELP/HOT LINE: 866-404-7539 OR EMAIL: Info@amyloidosissupport.com |
Familial(Hereditary) and Wild Type TTR (Senile) as well as other lesser known types.
TTR/Familial Support Meeting October 31, November 1, 2015
|
Meeting Notes for Saturday’s Plenary Sessions
8:00 - 8:05 - Welcome – Muriel BREAK- (15 minutes)
10:35 – 10:55 - Neuropathy- (Nerves before and after TTR)- why are nerves affected and what can be done, Carpal Tunnel, PN, AN – Click for Dr. Wiesman’s Presentation 12:05-1:00 – LUNCH
1:00 – 1:15 – Click for Alnylam Presentation Familial Survey Results – Click for Isabelle Lousada’s Presentation Afternoon Breakout SessionsNeuropathy - (Peripheral and Autonomic) - OH, GI, CT, etc., -WiesmanCardiac - (Symptoms, coping, treatments)- Grogan, Hanna, Heitner, Judge and Maurer NonATTR variants, eye issues, and organ transplants - (including ALEC2) - treatments, face and eye issues, kidney transplants, heart, liver too - Picken, Skinner, Stern, and Zeldenrust Genetic Issues - (When to tell the kids, when should I be tested? How?)- Sarah Mets Clinical Trials - (past, present and future) - Clinical Trial Reps along with Benson, Berk, Dispenzieri. Gertz and Kelly Caregiving and Coping - Mayo- PT- Katie Traver, Mayo OT-Sarah Dahlhauser, VA RN- Jean Adams, and ASG Paula
Q AND A WITH DOCTORS FACILITATED BY DR. GERTZ - Notes from Q and A (thanks to Joe)
2015 AMYLOIDOSIS SUPPORT MEETING SPEAKERSDr. Morie A Gertz, M.D., M.A.C.P., Chair. Roland Seidler Jr. Professor and Chair Department of Medicine. College of Medicine. Mayo Distinguished Clinician. Mayo Clinic, Rochester, MN. Departments: Hematology, Cancer and Transplant Centers. Special interest: Amyloidosis.Dr. Merrill D. Benson, Professor of Medicine, Professor of Medical Genetics. Indiana University. 2003 Pasteur-Weizmann/Servier International Prize in Biomedical Research. Interests: Amyloidosis, regula¬tion of gene expressions; synthesis and metabolism of plasma proteins. Dr. John L. Berk, Associate Professor of Medicine. Clinical Director, The Amyloidosis Center. Director, Localized Amyloid Clinic. Boston University School of Medicine. Interests: PI, Diflunisal Trial – FDA & NIH funded Radiotherapy for tracheobronchial Amyloidosis. Dr. Angela Dispenzieri. Mayo Clinic, Rochester, MN. President International Society of Amyloidosis. Research Interests: Plasma cell disorders like primary systemic amyloidosis, POEMS syndrome, mul¬tiple myeloma, and cryoglobulinemia. Dr. Martha Grogan. Assistant Professor of Medicine. Mayo Clinic, Rochester, MN. Cardiovascular Diseases. Interests: Amyloid heart disease; Echocardiography; Reversible cardiomyopathies. Dr. Mazen Hanna. Director of the Heart Failure Intensive Care Unit and Co-Director of the Amyloid Program. Cleveland Clinic. Interests: cardiomyopathy, heart failure, heart transplantation and mechanical circulatory assist devices, pulmonary hypertension, and cardiac amyloid. Sarah Mets, M.S. Mayo Clinic. Department of Medical Genetics, Cardiovascular Division Dr. Daniel Philip Judge. Director, Center for Inherited Heart Disease. Associate Professor of Medicine. Johns Hopkins Heart and Vascular Institute. Interests: Amyloid Diseases, Familial, Cardiomyopathy, Cardiovascular Diseases, ARVD - Genetics and Pathogenesis. Dr. Mathew S. Maurer. Medical Director, HCM Center at New York-Presbyterian/Columbia. Advanced training in heart failure and cardiac transplantation. Specializes in heart failure and preserved ejection fraction. Dr. Maria M. Picken, FASN. Professor. Director, Transplant Pathology. Interests: Amyloid, Genitourinary Pathology, Kidney Transplant and disease. Loyola University Health System, Maywood, IL. Dr. Jeffrey W. Kelly, Ph.D. Co-founder of FoldRx Pharmaceuticals, Boston, MA. 2003 - Enabled Vyndaqel (Tafamidis) European Drug Agency Approval in 2011 and Japanese approval (2013). This compound was discovered by, Professor Emerita. the Kelly Laboratory to treat Familial Amyloid. Dr. Martha Skinner Interim Director, Amyloidosis Center.. Director of Special Projects, Boston University School of Medicine. Interests: Treatment and research on Amyloidosis. Past President, International Society of Amyloidosis. Dr. Lauren D Stern. Assistant Professor of Medicine and Nephrology. Boston University School of Medicine. Interests: End stage renal disease; Pregnancy related kidney disease; Amyloidosis; Kidney stones; Electrolyte disorders. Dr. Janice F. Wiesman, Adjunct Assistant Professor of Neurology. Boston University School of Medicine. Interest: Electrodiagnostic Medicine. If you would like to talk, please call the ASG at 866-404-7539 toll free in the USA (leave a message if no one is there and you will be called back).
Available for online distribution: [English] [Spanish] [Portuguese] [French] [Italian] [German] [Dutch] [Japanese]
(TTR-FAP) Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy (PDF)
OUR 2013 MEETING NOTES Guest Doctors:
Morie Gertz
OUR 2011 MEETING DETAILS: 
OUR 2010 MEETING FEATURED THE FOLLOWING GUESTS:
by Dr. Skinner (PDF Document) Transplantation for Amyloidosis - 18 Years Later by Dr. Steven Zeldenrust Presentation by Dr. Marcia Waddington – Cruz Thank You flyer for all who spoke and attended DAY 1 OVERVIEW The first familial only meeting for patients as been a great success thus far. It started with a meet and greet Friday night at the local Marriot Courtyard in Wood Dale.... There were at least 50 people there and all enjoyed the 5-9 pm nibbles and sharing and eating and talking and eating....... After a hardy breakfast all met at Finkel Supply along with those that drove in, flew in late, or were local.....there were over 90 people..!!!!! Every doctor said they had never seen so many familial in one room before....and those wonderful doctors Dr. Martha Skinner, Dr. Morie Gertz, Dr. Steven Zeldenrust, Dr. John Berk, Dr. Merrill Benson, and Dr. Jared Gollob, Dr. Walter Singleton, Dr. Donna Grogan and Dr. Marcia Waddington-Cruz (the latter four part of on going trials) were informative, educational, helpful, supportive and in some cases even humorous. All returned to the hotel for a wonderful dinner and come back tomorrow for a Q and A session followed by lunch and then...home.... It was great to see how the inclement weather in various states including our own didn’t keep anyone away.....they came from the entire Pacific Coast.....Northeast, Middle Atlantic ......South, West and the Midwest......and even snowed in Denver....relatives meeting for the first time.....or reconnecting......and maybe even a new variant or two discovered.... Will fill all in on the Q and A should anything new and exciting pop up..... DAY 2 OVERVIEW
The group wrote down questions and Dr. Gertz fielded them and assigned them to each doctor for answers and discussion... ..It was quite lively, educational, occasionally humorous and always informative and right on. I would like to ask permission of all of the doctors to pass on the slides to all of the patients at the meeting.....hopefully we will get it..... For a doctor to give up one day for our meetings is most appreciated....to give up two is so far above and beyond and showed us all how necessary it was for the familial amyloidosis patients of the USA...to have their own meeting...to understand their own disease. ..to learn to cope, and find out what is being done to help them and future generations..... I am having the Q and A gone over by the doctors for their o.k. and then will put some of them out there for all....we don’t want to break any privacy issue....and we do thank the doctors again for their help, support, education, research, treatment, and anything else I may have left out.....oh forgot ...we finished up with a great lunch too, remember....FOOD IS SUPPORT.... and thank you to those members of the Chicago Area Support Group for helping out as well as Finkel Supply employees and dear friends...... All have been taken to the airport except for the night flights and those staying on a bit for site seeing.... The Marriot Courtyard gave all late check out and was so helpful as were out caterer whose staff VOLUNTEERED to stay on and serve.... .and wonderful Brook Furniture Rental for loaning us the chairs at NO CHARGE..... This meeting was all about giving........and it truly is a wonderful thing to be able to do.........  Dr. John Berk of Boston – our doctor of the month for December  Dr. Martha Skinner of Boston – and Muriel of the ASG  Dr. Merrill D. Benson of Indiana University Another name used for the disease in Portugal, named for Mário Corino da Costa Andrade TTR-FAP(Corino de Andrade's Disease) |
We started bright and early (for us on a Sunday 8:30) after a hardy breakfast at the hotel with a wonderful open forum Q and A.
The Doctors on the Panel were Drs. Benson, Berk, Zeldenrust and Drs. Grogan and Dr. Waddington-Cruz. The Moderator was
Dr. Gertz and I was part of the audience of patients, family members and care givers.....Dr. Grogan had to leave to get back but
Dr. Waddington – Cruz of Brazil stayed on until the end.
2023 ATTR CHICAGO MEETING
WEBINARS (Virtual Meetings)
Arizona (Phoenix)
California (Los Angeles)
California (San Diego)
Chicago
Colorado
Detroit
Florida (Jacksonville)
Florida (Miami)
Florida (Tampa)
Georgia/Alabama
Indianapolis
Kansas City
Louisiana
Maryland (Baltimore/D.C.)
Maryland (Hagerstown)
Massachusetts
Minnesota
Nevada
New York City
New York (Rochester)
North Carolina
OSU/Cleveland Clinic
Philadelphia
Portland
St. Louis
South Carolina
Texas (Dallas)
Texas (Houston)
Utah
Virginia
Washington (Seattle)
Washington (Spokane)
Washington DC
|
We invite our pharmaceutical liaisons to our support group meetings to help in our goal of educating and empowering our patients. The donations and/or grant received from these companies are unconditional, and the ASG does not endorse any one of their products over any other types of amyloidosis treatment. These treatments are mentioned at our meetings, on our website, and other electronic format for educational purposes. We encourage you to consult your amyloidosis professional when choosing a treatment plan. |
